For the quarter ending 2025-09-30, RKDA made $1,302,000 in revenue. $856,000 in net income. Net profit margin of 65.75%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Total revenues | 1,302,000 | - | 1,200,000 | 1,169,333.333 |
| Cost of revenues | 884,000 | - | 682,000 | 313,333.333 |
| Research and development | 0 | - | - | 9,666.667 |
| Gain on sale of intangible assets | 0 | - | 750,000 | 1,000,000 |
| Impairment of property and equipment | 0 | - | - | 9,000 |
| Change in fair value of contingent consideration | 0 | - | 1,000,000 | - |
| Selling, general and administrative | 1,570,000 | - | 1,738,000 | 2,466,666.667 |
| Total operating expenses | 2,454,000 | - | 670,000 | 1,798,666.667 |
| Loss from operations | -1,152,000 | - | 530,000 | -629,333.333 |
| Interest income | 7,000 | - | 207,000 | 183,000 |
| Credit loss | -257,000 | - | - | - |
| Other income | 1,698,000 | - | - | 5,333.333 |
| Change in fair value of common stock warrant and option liabilities | 560,000 | - | 1,862,000 | -601,333.333 |
| Net loss from continuing operations before income taxes | - | - | - | -1,042,333.333 |
| Income tax expense | - | - | - | 2,000 |
| Net income (loss) from continuing operations | 856,000 | - | 2,599,000 | -1,045,000 |
| Net loss from discontinued operations | 0 | - | - | -680,250 |
| Net loss | - | - | - | -1,808,666.667 |
| Net income (loss) attributable to common stockholders | 856,000 | -4,458,000 | 2,599,000 | -1,808,666.667 |
| Unrealized gains on available-for-sale securities | - | 0 | - | - |
| Reclassification adjustment for gains on available-for-sale securities included in net (loss) income | - | 0 | - | - |
| Change in unrealized gains on available-for-sale securities | - | 0 | - | - |
| Comprehensive (loss) income | - | -4,458,000 | - | - |
| Earnings per share, basic | 0.63 | -3.26 | 1.9 | -1.33 |
| Earnings per share, diluted | 0.62 | -3.26 | 1.9 | -1.33 |
| Weighted average shares - basic | 1,367,192 | 1,367,040 | 1,366,060 | -150 |
| Weighted average shares - diluted | 1,371,879 | 1,367,040 | 1,366,203 | -150 |
Arcadia Biosciences, Inc. (RKDA)
Arcadia Biosciences, Inc. (RKDA)